Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Future medicinal chemistry. 14(16),S. 1175-1186
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2023
- Creator
-
Opitz, Ansgar
Seitz, Lisa-Marie
Krystof, Vladimir
Baselious, Fady
Holzer, Max
Sippl, Wolfgang
Hilgeroth, Andreas
- URN
-
urn:nbn:de:bsz:15-qucosa2-879522
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:54 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Opitz, Ansgar
- Seitz, Lisa-Marie
- Krystof, Vladimir
- Baselious, Fady
- Holzer, Max
- Sippl, Wolfgang
- Hilgeroth, Andreas
- Universitätsbibliothek Leipzig
Time of origin
- 2023
Other Objects (12)
Propagation of Tau pathology in Alzheimer disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Tau spreading and accumulation with a focus on tyrosine kinases Pyk2 and Fyn in the context of Alzheimer‘s Disease
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Modulation of Alzheimer's pathology in transgenic mouse models
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Propagation of Tau pathology in Alzheimer disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Tau spreading and accumulation with a focus on tyrosine kinases Pyk2 and Fyn in the context of Alzheimer‘s Disease
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Modulation of Alzheimer's pathology in transgenic mouse models
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Propagation of Tau pathology in Alzheimer disease
Precortical phase of Alzheimer's disease (AD)-related tau cytoskeletal pathology
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Tau spreading and accumulation with a focus on tyrosine kinases Pyk2 and Fyn in the context of Alzheimer‘s Disease
Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Effects of amyloid and tau pathology on brain function and cognition in Alzheimer's disease
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Modulation of Alzheimer's pathology in transgenic mouse models